Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122294453 | 12229445 | 3 | F | 201507 | 20160812 | 20160401 | 20160912 | PER | US-JNJFOC-20160303093 | JANSSEN | 82.00 | YR | E | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122294453 | 12229445 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10-20MG | U | U | UNKNOWN | 0 | TABLET | ||||||
122294453 | 12229445 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 10-20MG | U | U | UNKNOWN | 0 | TABLET | ||||||
122294453 | 12229445 | 3 | PS | XARELTO | RIVAROXABAN | 1 | Oral | 10-20MG | U | U | UNKNOWN | 202439 | TABLET | ||||||
122294453 | 12229445 | 4 | SS | WARFARIN | WARFARIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
122294453 | 12229445 | 5 | C | HYDROCODEINE | DIHYDROCODEINE PHOSPHATE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
122294453 | 12229445 | 6 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
122294453 | 12229445 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
122294453 | 12229445 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122294453 | 12229445 | 1 | Thrombosis prophylaxis |
122294453 | 12229445 | 2 | Cerebrovascular accident prophylaxis |
122294453 | 12229445 | 3 | Atrial fibrillation |
122294453 | 12229445 | 4 | Product used for unknown indication |
122294453 | 12229445 | 5 | Product used for unknown indication |
122294453 | 12229445 | 6 | Product used for unknown indication |
122294453 | 12229445 | 7 | Product used for unknown indication |
122294453 | 12229445 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122294453 | 12229445 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122294453 | 12229445 | Dizziness | |
122294453 | 12229445 | Epistaxis | |
122294453 | 12229445 | Mouth haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122294453 | 12229445 | 1 | 201506 | 201507 | 0 | |
122294453 | 12229445 | 2 | 201506 | 201507 | 0 | |
122294453 | 12229445 | 3 | 201506 | 201507 | 0 |